Page 22 - SFHN1019pagesfinalUF.qxp_SFHN 0608 Friday 5.0

Oncology

PROFILES IN ONCOLOGY New Technology to Create

and Deliver Safe, Effective
JUPITER MEDICAL CENTER
Radiotherapy Plans

The Michael and Dianne
Shanel Bhagwandin, DO, MPH Bienes Comprehensive Cancer
Center at Holy Cross Hospital is
Dr. Shanel Bhagwandin is the medical director proud to announce the arrival
of the Gastrointestinal Surgical Oncology and commissioning of state-of-
Program at Jupiter Medical Center. A graduate of the-art radiotherapy equipment.
Lake Erie College of Osteopathic Medicine, Dr. The success of radiotherapy is
Bhagwandin completed his general surgery resi- dependent upon the ability to
dency at the University of Illinois at Chicago and methodically create a safe and
his fellowship training at the Icahn School of effective radiotherapy plan and
Medicine at Mount Sinai, New York. He is board thereafter ensure that treatment
certified in general surgery and in complex gen- delivery is both accurate and pre-
eral surgical oncology. Dr. Bhagwandin’s clinical cise. In order to achieve the
and research interests include the diagnosis and aforementioned goals, highly
treatment of complex malignancies of the liver, trained, certified and experi-
pancreas, and biliary tract, in addition to gastric enced medical teams along with
and esophageal cancer, colon and rectal cancer, sarcoma, and melanoma. He the finest equipment are neces-
specializes in the management of advanced peritoneal carcinomatosis sary.
through the application of Hyperthermic IntraPeritoneal Chemotherapy Radiotherapy begins with the
(HIPEC) and cytoreductive surgery, a technique that combines surgery with CT simulation process. This step
circulating hot chemotherapy directly into the abdomen. is done to help plan one's radio-
therapy by obtaining a CT scan that is used for subsequent treatment planning. Holy
Cross Hospital’s CT simulator is being upgraded with further 4-D capability to help
K. Adam Lee, MD, FACS follow and track one's breathing. This is particularly useful for treatment of thoracic
malignancies. Furthermore, Holy Cross can utilize approaches such as breath hold for
Dr. K. Adam Lee is a board-certified thoracic treatment of breast cancer.
surgeon, nationally recognized as a pioneer in Once a CT scan is ascertained, treatment planning ensues. Previous diagnostic
robotic-assisted thorascopic surgery, and a information including scans such as MRI, CT, and PET/CT are uploaded and fused by
leader in minimally invasive surgery techniques. Holy Cross Hospital’s physics and dosimetry team. At this time, the medical team
Dr. Lee serves as the medical director of the reviews the imaging and utilizes software to contour or draw the tumor as well as the
Thoracic Surgery and Lung Center and as chief rest of the patient's anatomy. The hospital is currently utilizing the treatment planning
of Surgical Oncology at Jupiter Medical Center. computer and electronic medical record systems of Pinnacle and Mosaiq for this pur-
He has developed a teaching site for electromag- pose and are looking forward to the addition of the advanced systems of Eclipse and
netic navigational bronchoscopy, as well as pre- ARIA. The purpose of treatment planning is to ensure a plan that delivers curative
sentations and publications for innovation in doses of radiotherapy while minimizing side effects. Once a plan is reviewed and
minimally invasive surgery, and the use of artifi- found to be optimal, Holy Cross will move on to the treatment delivery step.
cial intelligence for thoracic oncology. He also As a complement to the established Elekta equipment, Holy Cross is currently in
has spent many years traveling around the the process of installing the Varian True Beam linear accelerator for treatment delivery.
United States as an instructor for robotic thoracic surgery. Dr. Lee’s areas of Advanced treatment techniques such as volumetric-modulated arc therapy (VMAT),
special interest and research include multi-modality therapy for lung and stereotactic body radiotherapy (SBRT), and stereotactic radiotherapy (SRS) will be
esophageal cancer; surgery for higher stage lung cancer; minimally invasive delivered on this True Beam device. This machine will not only be the newest in the
surgery for lung and esophageal cancer; minimally invasive surgery for region, but also one of the most upgraded units in the country. As such, Varian, the
mediastinal disease; and robotic lobectomy for lung cancer and thymic dis- radiotherapy company, even proposed utilizing the Holy Cross cancer center to show-
ease processes. Dr. Lee is a trusted source to the media, having been featured case the innovative radiotherapy program. The hospital is also upgrading its
on ABC, NBC, CBS, and FOX both locally and nationally. brachytherapy units in order to provide not only traditional treatments for gynecol-
ogical and genitourinary malignancies, but also the treatment of skin and gastroin-
testinal diseases. These resources will also provide an opportunity for more clinical
trials at Holy Cross Hospital, which will have a unique department that supports both
Varian and Elekta machines to ensure that patients receive individualized care and are
treated on equipment that provide optimal and personalized treatment.

22 October 2019 southfloridahospitalnews.com South Florida Hospital News